Clinical trial
Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of…
NCT00355589 · Pfizer, Industry · Completed
Key facts
| NCT number | NCT00355589 |
|---|---|
| Title | Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension |
| Official title | A Randomized, Double-Blind, Multicenter, Parallel Study Evaluating the Efficacy and Safety of a Combination of Ramipril Plus Hydrochlorothiazide Versus the Component Monotherapies in Subjects With Essential Hypertension |
| Lead sponsor | Pfizer, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Hypertension, Blood Pressure, High |
| Intervention type | Drug |
| Interventions | Ramipril and hydrochlorothiazide |
| Start date | Jul 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Jul 24, 2006 |
| Last update posted | Oct 10, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: